For: | Shan DD, Zheng QX, Chen Z. Go-Ichi-Ni-San 2: A potential biomarker and therapeutic target in human cancers. World J Gastrointest Oncol 2022; 14(10): 1892-1902 [PMID: 36310704 DOI: 10.4251/wjgo.v14.i10.1892] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v14/i10/1892.htm |
Number | Citing Articles |
1 |
Jie Wei, Yujie Li, Wenqian Zhou, Xiaoya Ma, Jie Hao, Ting Wen, Bin Li, Tianbo Jin, Mingjun Hu. The construction of a novel prognostic prediction model for glioma based on GWAS-identified prognostic-related risk loci. Open Medicine 2024; 19(1) doi: 10.1515/med-2024-0895
|
2 |
Kaimin Guo, Jinna Yang, Ruonan Jiang, Xiaxia Ren, Peng Liu, Wenjia Wang, Shuiping Zhou, Xiaoguang Wang, Li Ma, Yunhui Hu. Identification of Key Immune and Cell Cycle Modules and Prognostic Genes for Glioma Patients through Transcriptome Analysis. Pharmaceuticals 2024; 17(10): 1295 doi: 10.3390/ph17101295
|
3 |
Hua He, Lu Liang, Shiyao Jiang, Yueying Liu, Jingjing Huang, Xiaoyan Sun, Yi Li, Yiqun Jiang, Li Cong. GINS2 regulates temozolomide chemosensitivity via the EGR1/ECT2 axis in gliomas. Cell Death & Disease 2024; 15(3) doi: 10.1038/s41419-024-06586-w
|